Exelixis, Inc.

NasdaqGS:EXEL

Market Cap

USD 12.32 B

Share Price

USD 44.86

Avg Daily Volume

3,359,838

Change (1 day)

-0.69%

Change (1 year)

98.94%

Change (YTD)

34.72%

Exelixis, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending April 04, 2025: 35.43%

Exelixis, Inc. EBIT Margin is 35.43% for the Trailing 12 Months (TTM) ending April 04, 2025, a 220.17% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Exelixis, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 29, 2024 was 11.07%, a 34.87% change year over year.
  • Exelixis, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 8.21%, a -65.90% change year over year.
  • Exelixis, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending April 01, 2022 was 24.06%, a 382.35% change year over year.
  • Exelixis, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending April 02, 2021 was 4.99%, a -85.36% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin